Search All News
Cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea regardless of CPAP use, suggests a new study from Columbia University.
After a sudden medical scare, many people develop a fear of health care and are afraid to adopt new health habits. The Center for Fearless Behavior Change is testing ways to help.
Iok In Christine Chio, PhD, and Oliver Clarke, PhD, early-career investigators at VP&S, are 2023 recipients of prestigious awards from the Irma T. Hirschl Trust Research Scientist Program.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
- March 15, 2022
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
- March 7, 2022
Two early-career scientists at Columbia University Vagelos College of Physicians and Surgeons—Minoree Kohwi, PhD, and Chao Lu, PhD—have been awarded prestigious 2022 Hirschl Trust Research Awards.
- March 4, 2022
What was learned by researchers during the pandemic has changed the mindset for scientists: “Why do we have to follow the old routine when we see a new paradigm working so well?”
- March 3, 2022
COVID vaccines and monoclonal antibody treatments offer less protection against new omicron subvariants, a new study from researchers at Columbia and University of Hong Kong finds.
- February 22, 2022
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
- February 17, 2022
An over-the-counter cough suppressant can knock some heart cells back into rhythm, a finding that may lead to a new way to treat a rare heart condition.
- February 14, 2022
A study of weight loss methods suggests that gastric bypass surgery is the best strategy for patients with type 2 diabetes and severe obesity, regardless of the severity of a patient’s diabetes.
- January 31, 2022
Columbia research has found that simple nutrient supplements, vitamin B3 and pyruvate, may prevent glaucoma.
- January 22, 2022
Based on Columbia research, an experimental drug for a rare type of ALS is being tested in a phase 3 clinical trial after a new study found that the drug lowered levels of a toxic protein.
- January 19, 2022
A new study at Columbia University Irving Medical Center seeks volunteers to determine if intermittent fasting leads to long-term weight loss and health benefits.